⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL513802 | 1.00 | — | — | |
| SCHEMBL7019591 | 0.74 | — | — | |
| SCHEMBL7019592 | 0.74 | — | — | |
| SCHEMBL97426 | 0.72 | — | — | |
| SCHEMBL2961645 | 0.72 | — | — | |
| SCHEMBL514442 | 0.72 | — | — | |
| SCHEMBL2961643 | 0.72 | — | — | |
| SCHEMBL514443 | 0.72 | — | — | |
| SCHEMBL97427 | 0.72 | — | — | |
| SCHEMBL5828905 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023210623-A1 | HALOALKYL SULFONE ANILIDE COMPOUND AND HERBICIDE CONTAINING SAME | 株式会社エス・ディー・エス バイオテック | 2023-11-02 | — | — | WO | disclosed |
| CN-102015718-B | 1- (7-(hexahydropyrrolo [3, 4-C] pyrrol-2 (1H) -yl) quin0lin-4-yl) -3- (pyrazin-2-yl) urea derivatives and related compounds as glycogen synthase kinase 3 (GSK-3) | ABBOTT GMBH & CO KG | 2014-12-10 | — | — | CN | disclosed |
| WO-2014184071-A1 | MIXTURES OF HALOALKYLSULFONANILIDE DERIVATIVES AND HERBICIDES | SYNGENTA LIMITED (GB) | 2014-11-20 | — | — | WO | disclosed |
| WO-2014184070-A1 | MIXTURES OF HALOALKYLSULFONANILIDE DERIVATIVES AND HERBICIDES | SYNGENTA LIMITED (GB) | 2014-11-20 | — | — | WO | disclosed |
| EP-1401829-B1 | NOVEL HETEROCYCLIC ANTIBACTERIAL COMPOUNDS | MICROBIOTIX INC (US) | 2012-08-22 | — | — | EP | disclosed |
| CN-102388034-A | Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors | ABBOTT GMBH & CO KG | 2012-03-21 | — | — | CN | disclosed |
| EP-2420493-A1 | HALOALKYLSULFONANILIDE DERIVATIVE | Nissan Chemical Industries, Ltd. (JP) | 2012-02-22 | — | — | EP | disclosed |
| US-20120029187-A1 | HALOALKYLSULFONANILIDE DERIVATIVE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-02-02 | — | — | US | disclosed |
| EP-2336104-A1 | ORTHO-SUBSTITUTED HALOALKYLSULFONANILIDE DERIVATIVE AND HERBICIDE | Nissan Chemical Industries, Ltd. (JP) | 2011-06-22 | — | — | EP | disclosed |
| US-20060258729-A1 | Antibacterial pyrazole carboxylic acid hydrazides | MICROBIOTIX, INC. | 2006-11-16 | — | — | US | disclosed |
| WO-2004094370-A2 | ANTIBACTERIAL PYRAZOLE CARBOXYLIC ACID HYDRAZIDES | MICROBIOTIX, INC. (US) | 2004-11-04 | — | — | WO | disclosed |
| EP-1401829-A4 | NOVEL HETEROCYCLIC ANTIBACTERIAL COMPOUNDS | MICROBIOTIX INC (US) | 2004-10-27 | — | — | EP | disclosed |
| US-20040171635-A1 | Novel tropane esters and methods for producing and using them | ENTROPIN, INC. | 2004-09-02 | — | — | US | disclosed |
| US-6777420-B2 | A URACIL COMPOUNDS AS ENZYME INHIBITORS, INHIBIT BACTERIAL DNA POLYMERASE, TREATING BACTERIAL DISEASES | MICROBIOTIX, INC. | 2004-08-17 | — | — | US | disclosed |
| WO-2004052888-A2 | TROPANE ESTERS AND METHODS FOR PRODUCING AND USING THEM | ENTROPIN, INC. (US) | 2004-06-24 | — | — | WO | disclosed |
| EP-1401829-A1 | NOVEL HETEROCYCLIC ANTIBACTERIAL COMPOUNDS | Microbiotix, Inc. (US) | 2004-03-31 | — | — | EP | disclosed |
| US-20030181719-A1 | Novel heterocyclic antibacterial compounds | MICROBIOTIX, INC. | 2003-09-25 | — | — | US | disclosed |
| WO-2002102792-A1 | NOVEL HETEROCYCLIC ANTIBACTERIAL COMPOUNDS | MICROBIOTIX, INC. (US) | 2002-12-27 | — | — | WO | disclosed |
| US-6211395-B1 | INTERMEDIATES IN THE PREPARATION OF CERTAIN PYRIDO(1,2-A)PYRIMIDINE AND QUINOLONE ANTIBACTERIAL AGENTS | ABBOTT LABORATORIES | 2001-04-03 | — | — | US | disclosed |
| US-6197974-B1 | CATALYTIC REDUCTION OF KETO B-ESTER; SULFONATION, CYCLIZATION, LACTAMIZATION, ACTIVATION, DEBLOCKING | ABBOTT LABORATORIES | 2001-03-06 | — | — | US | disclosed |